# Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer

> **NCT02258165** · — · COMPLETED · sponsor: **Queensland Centre for Gynaecological Cancer** · enrollment: 84 (actual)

## Conditions studied

- Ovarian Cancer Stage III
- Ovarian Cancer Stage IV

## Interventions

- **DEVICE:** PET/CT

## Key facts

- **NCT ID:** NCT02258165
- **Lead sponsor:** Queensland Centre for Gynaecological Cancer
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2020-10-10
- **Final completion:** 2022-12
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02258165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02258165, "Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02258165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*